Mylan N.V. (MYL) Receives “Market Perform” Rating from Cowen and Company
Mylan N.V. (NASDAQ:MYL)‘s stock had its “market perform” rating reaffirmed by research analysts at Cowen and Company in a research note issued to investors on Thursday. They presently have a $36.00 price objective on the stock, up from their prior price objective of $30.00. Cowen and Company’s price objective would suggest a potential downside of 4.76% from the stock’s previous close.
MYL has been the subject of several other reports. Cantor Fitzgerald initiated coverage on shares of Mylan N.V. in a research note on Friday, June 16th. They set a “neutral” rating and a $41.00 price objective for the company. Royal Bank Of Canada set a $41.00 price objective on shares of Mylan N.V. and gave the company a “hold” rating in a research note on Sunday, July 16th. BidaskClub upgraded shares of Mylan N.V. from a “strong sell” rating to a “sell” rating in a research note on Thursday, September 7th. BMO Capital Markets restated a “buy” rating and set a $45.00 price objective on shares of Mylan N.V. in a research note on Friday, September 29th. Finally, Mizuho restated a “buy” rating and set a $37.00 price objective (down from $53.00) on shares of Mylan N.V. in a research note on Sunday, August 20th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus target price of $42.34.
Shares of Mylan N.V. (NASDAQ MYL) opened at 37.80 on Thursday. Mylan N.V. has a one year low of $29.39 and a one year high of $45.87. The stock has a market capitalization of $20.27 billion, a PE ratio of 30.56 and a beta of 1.30. The firm’s 50-day moving average is $31.65 and its 200-day moving average is $36.47.
Mylan N.V. (NASDAQ:MYL) last released its earnings results on Wednesday, August 9th. The company reported $1.10 EPS for the quarter, missing analysts’ consensus estimates of $1.18 by ($0.08). The company had revenue of $2.96 billion during the quarter, compared to analyst estimates of $3 billion. Mylan N.V. had a return on equity of 22.42% and a net margin of 5.51%. The firm’s revenue for the quarter was up 15.7% on a year-over-year basis. During the same quarter last year, the business earned $1.16 earnings per share. On average, analysts expect that Mylan N.V. will post $4.52 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “Mylan N.V. (MYL) Receives “Market Perform” Rating from Cowen and Company” was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this story on another publication, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be viewed at https://www.watchlistnews.com/mylan-n-v-myl-receives-market-perform-rating-from-cowen-and-company/1609591.html.
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Wellington Management Group LLP increased its holdings in Mylan N.V. by 2.6% in the 1st quarter. Wellington Management Group LLP now owns 46,373,108 shares of the company’s stock worth $1,808,088,000 after acquiring an additional 1,165,852 shares in the last quarter. BlackRock Inc. increased its holdings in Mylan N.V. by 4.5% in the 2nd quarter. BlackRock Inc. now owns 40,574,158 shares of the company’s stock worth $1,575,089,000 after acquiring an additional 1,751,515 shares in the last quarter. Vanguard Group Inc. increased its holdings in Mylan N.V. by 12.0% in the 2nd quarter. Vanguard Group Inc. now owns 32,880,790 shares of the company’s stock worth $1,276,432,000 after acquiring an additional 3,531,974 shares in the last quarter. State Street Corp increased its holdings in Mylan N.V. by 1.6% in the 2nd quarter. State Street Corp now owns 20,498,541 shares of the company’s stock worth $795,751,000 after acquiring an additional 321,977 shares in the last quarter. Finally, Pzena Investment Management LLC increased its holdings in Mylan N.V. by 69.9% in the 2nd quarter. Pzena Investment Management LLC now owns 12,339,687 shares of the company’s stock worth $479,027,000 after acquiring an additional 5,077,371 shares in the last quarter. 71.97% of the stock is owned by institutional investors.
Mylan N.V. Company Profile
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.